Acasti PharmaCompany Review & Valuation

ACST
TSX Venture Exchange
Latest Price
0.24CAD
Market Capitalization
21.65mCAD

About Acasti Pharma Inc.

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patieShow morents with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada.Show less

Industry
Biotechnology
HQ Location
Laval, Canada

Stock Price

Price data not available for Acasti Pharma.

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

MannKind Corporation
Shire
KalVista Pharmaceuticals
Celgene

back to top